|
ZNHIT6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.94300197731945E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.50159995127819E-09 |
| Normal-vs-Stage2 |
3.60789999986899E-07 |
| Normal-vs-Stage3 |
3.90169996311585E-09 |
| Normal-vs-Stage4 |
8.20279999480533E-09 |
| Stage1-vs-Stage2 |
3.439200E-01 |
| Stage1-vs-Stage3 |
2.189000E-01 |
| Stage1-vs-Stage4 |
2.188200E-01 |
| Stage2-vs-Stage3 |
9.732800E-01 |
| Stage2-vs-Stage4 |
8.502200E-01 |
| Stage3-vs-Stage4 |
8.015600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17819975997691E-10 |
| Normal-vs-AfricanAmerican |
3.280100E-03 |
| Normal-vs-Asian |
2.45020000000373E-06 |
| Caucasian-vs-AfricanAmerican |
2.062800E-01 |
| Caucasian-vs-Asian |
8.605800E-01 |
| AfricanAmerican-vs-Asian |
3.329400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.71039857224764E-11 |
| Normal-vs-Female |
2.80059997415094E-09 |
| Male-vs-Female |
1.195250E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.18690000342426E-08 |
| Normal-vs-Age(41-60Yrs) |
2.13929995940276E-09 |
| Normal-vs-Age(61-80Yrs) |
1.04419994872984E-09 |
| Normal-vs-Age(81-100Yrs) |
5.152300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.707000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.177400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.532600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.430400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.298200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.202800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.791220E-01 |
| Classical-VS-Follicular |
3.938100E-02 |
| Classical-VS-Other |
5.730000E-01 |
| Classical-VS-Normal |
1.40670000092769E-08 |
| Tall-VS-Follicular |
8.065800E-01 |
| Tall-VS-Other |
8.953400E-01 |
| Tall-VS-Normal |
1.16169999997418E-06 |
| Follicular-VS-Other |
8.367400E-01 |
| Follicular-VS-Normal |
3.98380000099507E-08 |
| Other-VS-Normal |
9.082400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.44980036256948E-10 |
| Normal-vs-N1 |
1.49250000136547E-08 |
| N0-vs-N1 |
5.552800E-01 |
|
|
